1. Home
  2. CDLX vs GDTC Comparison

CDLX vs GDTC Comparison

Compare CDLX & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$1.27

Market Cap

10.1M

Sector

Technology

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

SELL

Current Price

$0.80

Market Cap

10.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CDLX
GDTC
Founded
2008
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
10.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
CDLX
GDTC
Price
$1.27
$0.80
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $4.43
N/A
AVG Volume (30 Days)
★ 61.1K
11.6K
Earning Date
11-05-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 50.13
N/A
EPS
N/A
★ N/A
Revenue
★ $233,273,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.53
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.55
$0.68
52 Week High
$6.40
$2.29

Technical Indicators

Market Signals
Indicator
CDLX
GDTC
Relative Strength Index (RSI) 27.28 34.42
Support Level $0.85 $0.73
Resistance Level $2.32 $1.07
Average True Range (ATR) 0.19 0.06
MACD -0.01 -0.01
Stochastic Oscillator 2.83 0.00

Price Performance

Historical Comparison
CDLX
GDTC

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: